A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma†
Giuseppe Cabibbo(Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo), Calogero Cammà(Department of Health)
Cited by 479
Related Papers
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
|Journal of Hepatology|2019|205
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2019|152